Sanofi (Sanofi) FCF Yield % : 4.73 (As of Apr. 27, 2024)

View and export this data going back to 2002. Start your Free Trial

What is Sanofi FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Sanofi's Trailing 12-Month Free Cash Flow is $5,799 Mil, and Market Cap is $122,651 Mil. Therefore, Sanofi's FCF Yield % for today is 4.73%.

The historical rank and industry rank for Sanofi's FCF Yield % or its related term are showing as below:

SNY' s FCF Yield % Range Over the Past 10 Years
Min: 3.15 Med: 5.8 Max: 8.6
Current: 4.73

During the past 13 years, the highest FCF Yield % of Sanofi was 8.60%. The lowest was 3.15%. And the median was 5.80%.

SNY's FCF Yield % is ranked better than
77.96% of 1080 companies
in the Drug Manufacturers industry
Industry Median: -0.655 vs SNY: 4.73

Sanofi's FCF Margin % for the quarter that ended in Jun. 2023 was 0.00%.

Sanofi FCF Yield % Historical Data

The historical data trend for Sanofi's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sanofi FCF Yield % Chart

Sanofi Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Yield %

Get a 7-Day Free Trial

5.23

5.34

7.63

7.22

6.34

Sanofi Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
FCF Yield %	Get a 7-Day Free Trial															-	4.81	9.50	-	-

Competitive Comparison of Sanofi's FCF Yield %

For the Drug Manufacturers - General subindustry, Sanofi's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sanofi's FCF Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sanofi's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Sanofi's FCF Yield % falls into.

Sanofi FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Sanofi's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	7888.768	/	124459.271
	=	6.34%

Sanofi's annualized FCF Yield % for the quarter that ended in Jun. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	0	*	2	/	134910.083
	=	0.00%

Sanofi FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Sanofi FCF Yield % Related Terms

Thank you for viewing the detailed overview of Sanofi's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Sanofi (Sanofi) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sanofi SA (NAS:SNY) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

SNYNF:USA SNY:Mexico SANF:Italy 0A2V:UK SANp:UK 0O59:UK SAN:France SNW:Germany SNW2:Germany SNW:Germany SNW:Germany SNW2:Germany SNW:Germany SANO:Austria

Address

46, avenue de la Grande Armée, Paris, FRA, 75017

Website

https://www.sanofi.com

Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 15% of total sales, but profits are shared with Regeneron. About 40% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.